Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom
Portfolio Pulse from
Nanowear has announced a licensing and data partnership with Dexcom to integrate continuous glucose monitoring (CGM) data into its SimpleSense™ platform. This collaboration will enable real-time, comprehensive cardiometabolic diagnostic assessments across multiple health parameters, targeting pharmaceutical, medtech, and research communities.
March 25, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Dexcom's G7 CGM system will be integrated into Nanowear's diagnostic platform, potentially expanding its market penetration and demonstrating technological versatility in health monitoring.
Partnership provides Dexcom with additional exposure in clinical research and direct-to-consumer markets, potentially increasing platform adoption and visibility
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 85